Medicine Supply Notification: Estriol (Ovestin® ) 1mg cream
THIS CONTENT HAS NOW EXPIRED
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estriol (Ovestin®) 1mg cream.
MSN/2022/038
Tier 2 – medium impact
Date of issue 3rd May 2022
- Estriol (Ovestin®) 1mg cream is experiencing intermittent supply issues until July 2022.
- A Serious Shortage Protocol (SSP) was issued on 29/04/2022.
- Alternative hormone replacement therapies remain available
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.